-+ 0.00%
-+ 0.00%
-+ 0.00%

Flerie Commits to Pro Rata Share of Xspray Pharma's SEK 90 Million Rights Issue

PUBT·11/06/2026 08:31:25
Listen to the news
Flerie Commits to Pro Rata Share of Xspray Pharma's SEK 90 Million Rights Issue
  • Flerie will subscribe for its pro rata share of Xspray Pharma’s approximately SEK 90 million rights issue.
  • Its existing stake in Xspray Pharma is 17%.
  • Xspray Pharma has secured approximately SEK 104 million in subscription commitments for the rights issue and an overallotment issue.
  • Proceeds will support Dasynoc and Nilopki launch preparations, advance the development pipeline and strengthen future manufacturing capacity.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Flerie AB published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.